Lakewood-Amedex Biotherapeutics (LABT) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.61, -3.17% vs the prior close of $0.63.
- Volume 148.30K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LABT slides 3.2% to $0.61, a 6-month low, 7 down days in a row. Closed at $0.61, -3.17% vs the prior close of $0.63. Day range $0.58–$0.63, opened at $0.60.
LABT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LABT slides 3.2% to $0.61, a 6-month low, 7 down days in a row
- Closed at $0.61, -3.17% vs the prior close of $0.63. Day range $0.58–$0.63, opened at $0.60.
- Volume was 148.30K shares, 0.1x its 50-day average of 1.50M — lighter than usual.
- Price is -66.1% vs its 50-day average ($1.80).
- 52-week range $0.58–$98.20; today's close sits at 0% of that range, 99.4% below the 52-week high.
- That makes 7 straight losses.
Oct 14, 2026 — LABT slides 8.7% to $0.63, a 6-month low, 6 down days in a row
- Closed at $0.63, -8.70% vs the prior close of $0.69. Day range $0.62–$0.71, opened at $0.67.
- Volume was 133.90K shares, 0.1x its 50-day average of 1.50M — lighter than usual.
- Price is -65.7% vs its 50-day average ($1.84).
- 52-week range $0.62–$98.20; today's close sits at 0% of that range, 99.4% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — LABT slides 5.5% to $0.69, a 6-month low, 5 down days in a row
- Closed at $0.69, -5.48% vs the prior close of $0.73. Day range $0.67–$0.73, opened at $0.73.
- Volume was 152.70K shares, 0.1x its 50-day average of 1.50M — lighter than usual.
- Price is -63.1% vs its 50-day average ($1.87).
- 52-week range $0.67–$98.20; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — LABT slides 6.4% to $0.73, a 6-month low, 4 down days in a row
- Closed at $0.73, -6.41% vs the prior close of $0.78. Day range $0.73–$0.77, opened at $0.77.
- Volume was 160.70K shares, 0.1x its 50-day average of 1.50M — lighter than usual.
- Price is -61.5% vs its 50-day average ($1.90).
- 52-week range $0.73–$98.20; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — LABT dips 1.3% to $0.78, a 6-month low, 3 down days in a row
- Closed at $0.78, -1.27% vs the prior close of $0.79. Day range $0.78–$0.82, opened at $0.79.
- Volume was 118.10K shares, 0.1x its 50-day average of 1.50M — lighter than usual.
- Price is -59.4% vs its 50-day average ($1.92).
- 52-week range $0.76–$98.20; today's close sits at 0% of that range, 99.2% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — LABT slides 7.1% to $0.79, a 6-month low
- Closed at $0.79, -7.06% vs the prior close of $0.85. Day range $0.78–$0.83, opened at $0.82.
- Volume was 216.80K shares, 0.1x its 50-day average of 1.50M — lighter than usual.
- Price is -59.4% vs its 50-day average ($1.95).
- 52-week range $0.76–$98.20; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 7, 2026 — LABT dips 2.3% to $0.85 on 6.4x normal volume
- Closed at $0.85, -2.30% vs the prior close of $0.87. Day range $0.76–$0.90, opened at $0.78.
- Volume was 8.50M shares, 6.4x its 50-day average of 1.34M — unusually heavy trading.
- Price is -56.8% vs its 50-day average ($1.97).
- 52-week range $0.76–$98.20; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 6, 2026 — LABT rises 2.4% to $0.87
- Closed at $0.87, +2.35% vs the prior close of $0.85. Day range $0.83–$0.87, opened at $0.86.
- Volume was 149.70K shares, 0.1x its 50-day average of 1.34M — lighter than usual.
- Price is -56.4% vs its 50-day average ($1.99).
- 52-week range $0.82–$98.20; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 5, 2026 — LABT slides 8.6% to $0.85, a 3-month low, 7 down days in a row
- Closed at $0.85, -8.60% vs the prior close of $0.93. Day range $0.82–$0.89, opened at $0.88.
- Volume was 272.20K shares, 0.2x its 50-day average of 1.34M — lighter than usual.
- Price is -58.1% vs its 50-day average ($2.03).
- 52-week range $0.82–$98.20; today's close sits at 0% of that range, 99.1% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — LABT ends flat (+0.0%) to $0.93, 6 down days in a row
- Closed at $0.93, +0.00% vs the prior close of $0.93. Day range $0.91–$0.95, opened at $0.93.
- Volume was 120.50K shares, 0.1x its 50-day average of 1.38M — lighter than usual.
- Price is -54.9% vs its 50-day average ($2.06).
- 52-week range $0.91–$98.20; today's close sits at 0% of that range, 99.1% below the 52-week high.
- That makes 6 straight losses.
LABT latest news & SEC filings
Every SEC filing by or about LABT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 24, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 18, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.77M (prior year -$655.94K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$2.75 (prior year -$1.66) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 10, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Jul 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 23, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 22, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade LABT
- How much it moves: over the last 20 sessions the average daily move was 6.58% (largest 31.1%). That is a volatile stock.
- Liquidity: about 2.42M shares (≈$1.47M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.61 vs a range of $0.58–$98.20 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Jun 22, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 10-Q Aug 14, 2026; 8-K Jul 15, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LABT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.60 | 0.63 | 0.58 | 0.61 | 148.30K |
| Oct 14, 2026 | 0.67 | 0.71 | 0.62 | 0.63 | 133.90K |
| Oct 13, 2026 | 0.73 | 0.73 | 0.67 | 0.69 | 152.70K |
| Oct 12, 2026 | 0.77 | 0.77 | 0.73 | 0.73 | 160.70K |
| Oct 9, 2026 | 0.79 | 0.82 | 0.78 | 0.78 | 118.10K |
| Oct 8, 2026 | 0.82 | 0.83 | 0.78 | 0.79 | 216.80K |
| Oct 7, 2026 | 0.78 | 0.90 | 0.76 | 0.85 | 8.50M |
| Oct 6, 2026 | 0.86 | 0.87 | 0.83 | 0.87 | 149.70K |
| Oct 5, 2026 | 0.88 | 0.89 | 0.82 | 0.85 | 272.20K |
| Oct 2, 2026 | 0.93 | 0.95 | 0.91 | 0.93 | 120.50K |
| Oct 1, 2026 | 0.94 | 0.96 | 0.91 | 0.93 | 170.30K |
| Sep 30, 2026 | 0.97 | 0.98 | 0.92 | 0.96 | 401.80K |
| Sep 29, 2026 | 1.09 | 1.09 | 0.92 | 0.99 | 1.29M |
| Sep 28, 2026 | 2.06 | 2.13 | 1.10 | 1.15 | 35.36M |
| Sep 25, 2026 | 1.85 | 1.85 | 1.63 | 1.67 | 176.00K |
| Sep 24, 2026 | 1.76 | 1.85 | 1.69 | 1.83 | 101.50K |
| Sep 23, 2026 | 1.97 | 2.00 | 1.78 | 1.78 | 109.80K |
| Sep 22, 2026 | 2.08 | 2.10 | 1.90 | 1.99 | 128.40K |
| Sep 21, 2026 | 1.99 | 2.08 | 1.92 | 2.05 | 361.80K |
| Sep 18, 2026 | 1.92 | 2.15 | 1.89 | 1.99 | 281.20K |
About Lakewood-Amedex Biotherapeutics
Lakewood-Amedex Biotherapeutics (LABT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in UNIVERSITY PARK, FL. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 2079272.
LABT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kelvin Cooper | Chief Executive Officer | May 1, 2026 |
| Leonard James Deroma | Director | May 1, 2026 |
| Joseph Edward Tucker | Director | May 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Thomas Balzer | Chief Medical Officer | May 1, 2026 |
| Peter Ceccacci | Chief Financial Officer | May 1, 2026 |
| Kelvin Cooper | Chief Executive Officer | May 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LABT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $4.96M, total liabilities $628.93K, cash $2.58M (as of Jun 30, 2026).
LABT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LABT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.